Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020097561 - ANTIBODIES RECOGNIZING TAU

Publication Number WO/2020/097561
Publication Date 14.05.2020
International Application No. PCT/US2019/060616
International Filing Date 08.11.2019
IPC
C07K 16/18 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
C07K 16/44 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
44against material not provided for elsewhere
Applicants
  • PROTHENA BIOSCIENCES LIMITED [IE]/[IE]
  • NIJJAR, Tarlochan S. [US]/[US]
  • BARBOUR, Robin [US]/[US]
  • DOLAN, Philip James [US]/[US]
  • LIU, Yue [US]/[US]
  • ALEXANDER, Svetlana [US]/[US]
  • RENZ, Mark [US]/[US]
Inventors
  • NIJJAR, Tarlochan S.
  • BARBOUR, Robin
  • DOLAN, Philip James
  • LIU, Yue
  • ALEXANDER, Svetlana
  • RENZ, Mark
Agents
  • SATHER, Susan
  • LIEBESCHUETZ, Joe
  • CELLI, Rosemarie
  • SCHILLING, Stephen H.
  • CHANG, Cindy
Priority Data
62/758,42109.11.2018US
PCT/US2018/05989508.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTIBODIES RECOGNIZING TAU
(FR) ANTICORPS RECONNAISSANT LA PROTÉINE TAU
Abstract
(EN)
The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
(FR)
L’invention concerne des anticorps qui se lient spécifiquement à la protéine tau. Ces anticorps inhibent ou retardent les pathologies associées à tau et la détérioration symptomatique associée.
Latest bibliographic data on file with the International Bureau